(ENTA) Enanta Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Enanta Pharmaceuticals | (ENTA) share price targets
Complete technical analysis of Enanta Pharmaceuticals (ENTA) by charts plus indicators, forecast predictions and share price targets for Enanta Pharmaceuticals (ENTA)
Enanta Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Enanta Pharmaceuticals is 141766
| Date | Daily Closing Price | Open | High | Low | Volume |
| 01 Wed Feb 2023 | 51.91 | 53.29 | 54.20 | 50.14 | 0.931 times |
| 31 Tue Jan 2023 | 53.38 | 51.42 | 53.70 | 50.39 | 1.337 times |
| 30 Mon Jan 2023 | 50.95 | 51.74 | 52.22 | 50.65 | 0.738 times |
| 27 Fri Jan 2023 | 52.02 | 51.34 | 52.20 | 50.40 | 0.74 times |
| 26 Thu Jan 2023 | 51.51 | 51.67 | 52.60 | 50.15 | 0.588 times |
| 25 Wed Jan 2023 | 51.49 | 51.07 | 52.44 | 50.45 | 0.965 times |
| 24 Tue Jan 2023 | 51.82 | 49.45 | 52.73 | 49.45 | 0.918 times |
| 23 Mon Jan 2023 | 49.54 | 50.21 | 50.86 | 48.96 | 0.961 times |
| 20 Fri Jan 2023 | 50.28 | 51.18 | 51.18 | 48.80 | 1.583 times |
| 19 Thu Jan 2023 | 50.40 | 49.04 | 51.19 | 48.02 | 0.811 times |
My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 52.1 as stoploss in an intra day sell trade for a target of 50.34. However, stock will show a bullish move above 52.1.
Share price targets for Enanta Pharmaceuticals (ENTA)
| Target Type | Value |
| Downside Target | 39.60 |
| Downside Target | 40.89 |
| Downside Target | 44.07 |
| Downside Target | 46.80 |
| Downside Target | 47.93 |
| Downside Target | 51.56 |
| Upside Target | 52.73 |
| Upside Target | 54.09 |
| Upside Target | 54.20 |
Intraday share price targets for Enanta Pharmaceuticals (ENTA)
| Target Type | Value |
| Downside Intraday Target | 49.97 |
| Downside Intraday Target | 48.02 |
| Upside Intraday Target | 54.03 |
| Upside Intraday Target | 56.14 |
| Upside Intraday Target | 52.08 |
Weekly technical analysis of Enanta Pharmaceuticals (ENTA)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 01 Wed Feb 2023 | 51.91 | 51.74 | 54.20 | 50.14 | 0.721 times |
| 27 Fri Jan 2023 | 52.02 | 50.21 | 52.73 | 48.96 | 0.847 times |
| 20 Fri Jan 2023 | 50.28 | 51.56 | 51.56 | 48.02 | 10.832 times |
| 13 Fri Jan 2023 | 49.84 | 51.95 | 54.09 | 49.61 | 0.073 times |
| 13 Fri Jan 2023 | 51.46 | 50.03 | 54.09 | 46.80 | 2.462 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Enanta Pharmaceuticals (ENTA)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 01 Wed Feb 2023 | 51.91 | 53.29 | 54.20 | 50.14 | 0.046 times |
| 31 Tue Jan 2023 | 53.38 | 46.73 | 54.09 | 44.47 | 0.966 times |
| 30 Fri Dec 2022 | 46.52 | 44.01 | 47.93 | 40.89 | 0.719 times |
| 30 Wed Nov 2022 | 43.79 | 45.69 | 49.70 | 39.60 | 1.033 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Enanta Pharmaceuticals (ENTA)
| Indicator Name | Indicator Value | Indicator Signal |
| ADX | 17, 5, 52 | Buy |
| MACD | 3, 2 | Buy |
| Stochastics | 73 | Buy |
| CCI | 86 | Sell |
| RSI | 55 | Buy |
| OBV | 385244 | Sell |
| VWAP | 51 | Buy |
| ADL | 0 | Sell |
| ROC | 5 | Buy |
| Force Index | 0 | Sell |
Price action analysis of Enanta Pharmaceuticals ( (ENTA) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Enanta Pharmaceuticals ( (ENTA) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Enanta Pharmaceuticals ( (ENTA) ) based on a short to mid term time period is
Price action analysis of Enanta Pharmaceuticals ( (ENTA) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Enanta Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Enanta Pharmaceuticals in short term and the buy signal is strong.
Enanta Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Enanta Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Enanta Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 51.34 and Enanta Pharmaceuticals (ENTA) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Enanta Pharmaceuticals (ENTA) stock. Volume based technical analysis of Enanta Pharmaceuticals (ENTA) stock is negative.
Enanta Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Daily charts
NSE Gainers NSE Losers BSE Gainers BSE Losers
Munafa NEWSTerms of Use Create Support ticket Your support tickets Powered by ePowerPress Stock Market News! Top Seo SMO © munafa.biz2023 All Rights reserved.